SG Americas Securities
ADPT icon

SG Americas Securities’s Adaptive Biotechnologies ADPT Stock Holding History

SG Americas Securities’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Sell
117,909
-19,849
-14% -$304K ﹤0.01% 1390
2026
Q1 		$1.91M Buy
137,758
+37,823
+38% +$603K ﹤0.01% 1417
2025
Q4 		$1.62M Buy
99,935
+31,822
+47% +$519K ﹤0.01% 1661
2025
Q3 		$1.02M Buy
68,113
+30,785
+82% +$375K ﹤0.01% 1435
2025
Q2 		$435K Buy
37,328
+12,963
+53% +$118K ﹤0.01% 1762
2025
Q1 		$181K Sell
24,365
-21,579
-47% -$166K ﹤0.01% 2599
2024
Q4 		$275K Buy
45,944
+4,799
+12% +$26.5K ﹤0.01% 1865
2024
Q3 		$211K Buy
41,145
+19,478
+90% +$84.9K ﹤0.01% 2445
2024
Q2 		$78K Buy
+21,667
New +$68.8K ﹤0.01% 2599
2024
Q1 		– Sell
-70,571
Closed -$346K – 2928
2023
Q4 		$346K Buy
70,571
+11,851
+20% +$54.1K ﹤0.01% 1708
2023
Q3 		$320K Buy
58,720
+18,658
+47% +$123K ﹤0.01% 2038
2023
Q2 		$269K Sell
40,062
-36,792
-48% -$274K ﹤0.01% 1669
2023
Q1 		$679K Buy
76,854
+47,892
+165% +$422K 0.01% 1467
2022
Q4 		$221K Buy
28,962
+5,339
+23% +$41.5K ﹤0.01% 2120
2022
Q3 		$168K Sell
23,623
-27,055
-53% -$255K ﹤0.01% 2452
2022
Q2 		$410K Buy
50,678
+25,439
+101% +$224K ﹤0.01% 2134
2022
Q1 		$350K Buy
25,239
+1,363
+6% +$21.4K ﹤0.01% 2109
2021
Q4 		$670K Buy
23,876
+13,262
+125% +$406K ﹤0.01% 1944
2021
Q3 		$361K Buy
10,614
+2,969
+39% +$107K ﹤0.01% 2779
2021
Q2 		$312K Sell
7,645
-18,656
-71% -$725K ﹤0.01% 2148
2021
Q1 		$1.06M Buy
26,301
+24,283
+1,203% +$1.31M 0.01% 1500
2020
Q4 		$119K Sell
2,018
-8,964
-82% -$462K ﹤0.01% 2943
2020
Q3 		$534K Buy
+10,982
New +$462K ﹤0.01% 1594
2020
Q1 		– Sell
-6,520
Closed -$195K – 3413
2019
Q4 		$195K Buy
+6,520
New +$187K ﹤0.01% 2492
2019
Q3 		– Sell
-15,000
Closed -$724K – 2972
2019
Q2 		$724K Buy
+15,000
New +$665K 0.01% 1651

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

SG Americas Securities's ADPT Position: Q2 2026 in Review

SG Americas Securities reduced its Adaptive Biotechnologies (ADPT) stake by 14% in Q2 2026, selling an estimated $304K and leaving 117,909 shares worth $2.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1390.

SG Americas Securities first reported a position in ADPT in Q2 2019 and has held it in 25 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • SG Americas Securities held 117,909 shares of Adaptive Biotechnologies worth $2.53M as of Q2 2026.
  • SG Americas Securities sold 19,849 Adaptive Biotechnologies shares in Q2 2026, an estimated $304K.
  • Adaptive Biotechnologies made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1390 holding.
  • SG Americas Securities first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 25 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.